Vistra Corp. VST stands well-positioned for long-term growth, backed by its strategic capital allocation plan. As the energy ...

In trading on Tuesday, shares of Catalyst Pharmaceuticals Inc (Symbol: CPRX) entered into oversold territory, hitting an RSI reading of 29.7, after changing hands as low as $21.1648 per share.

Free speech or disruptive behavior? After a viral confrontation with a conservative social media personality in May, the LDDA is looking for guidance.

The CATalyst Council, the veterinary industry’s leading authority on the feline market, released Volume II of its 2025 Feline Market Insights Report.

The CATalyst Council, the veterinary industry’s leading authority on the feline market, released Volume II of its 2025 Feline Market Insights Report. This da ...

Police across Europe have dismantled a dark web drug marketplace known as 'Archetyp Market', the pan-European Europol police body said on Monday, which added that U.S. authorities had also ...

The CATalyst Council, the veterinary industry’s leading authority on the feline market, released Volume II of its 2025 Feline Market Insights Report. This data-driven resource offers an in-depth ...

Novel catalyst cleaves carbon–fluorine bonds to break down 'forever chemicals' by Markus Bernards, Goethe University Frankfurt am Main edited by Lisa Lock, reviewed by Robert Egan Editors' notes ...

Research, published in Chem, provides a holistic understanding of the light-driven production of hydrogen gas using a nanocrystal- enzyme complex as the catalyst, and a computational framework ...

The company has collected $170 million in new capital as it seeks to help connect data centers and other businesses in the age of artificial intelligence.

Revenue Growth: Catalyst Pharmaceuticals's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 43.56%.